Although it has not been previously tested in PTHS models, early reinstatement of TCF4 during neurodevelopment is expected to provide the greatest therapeutic benefit similar to other neurodevelopment-related genes and their respective disorders. The gene discussed is TCF4; the disease is Pitt-Hopkins syndrome.